Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021)

PROCEPT BioRobotics has reported Preferred Stock Liabilities over the past 2 years, most recently at $328.6 million for Q2 2021.

  • Quarterly Preferred Stock Liabilities changed N/A to $328.6 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $328.6 million through Jun 2021, changed N/A year-over-year, with the annual reading at $243.9 million for FY2020, N/A changed from the prior year.
  • Preferred Stock Liabilities was $328.6 million for Q2 2021 at PROCEPT BioRobotics, up from $243.9 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $328.6 million in Q2 2021 and troughed at $243.9 million in Q3 2020.